International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 887

PDF Downloaded: 638


Get Permission Mahendran and Santhi: Evaluation of YKL-40, C- reactive protein and uric acid levels in hypertensive patients


Introduction

Hypertension is a major public health problem and leads cardiovascular disease, including stroke, heart attack, heart failure, aneurysm, renal and other vascular complications.1, 2 Inflammatory cytokines play a major role in vascular inflammation which leads to endothelial dysfunction further leads to vascular complications.3, 4 YKL‐40 is human glycoprotein produced by various cell types such as macrophages, neutrophils, chondrocytes, vascular smooth muscle cells and by inflamed tissues.5, 6, 7 YKL‐40 is consider as acute‐phase reactant and its expression induced by Interleukin-6. Studies reported that Chitinase family glycosidases involved tissue remodeling, fibrosis and expressed in various disease states.8, 9, 10, 11

C-reactive protein (CRP) is pentraxin produced by the liver. Its levels are associated with inflammation, play a major role aetiopathogenesis of arterial atherothrombosis and used to evaluate your risk of developing coronary artery disease.12, 13

Uric acid is the end product of purine metabolism. Studies reported that acid stimulates inflammation, proliferation, oxidativestress in vascular smooth-muscle cells and lead endothelial dysfunction system.14, 15 So, in the present study we aimed to explore serum YKL-40 levels in hypertensive patients compared with healthy controls and its association with CRP and uric acid.

Materials and Methods

Fifty hypertensive patient of both sexes with age group between 35-50 years according to JNC-8 (Eighth Joint National Committee) guidelines attending Department of General Medicine, Nimra Institute of Medical sciences, Jupudi, Andhra pradesh state, India were selected for present study. The study was approved by Institutional Human ethics committee (IHEC) and informed consent was obtained from each subject before sample collection and general examination and experiments were performed in accordance with Helsinki declaration of 1975. Hypertensive subjects - systolic blood pressure (≥140) or diastolic blood pressure (≥90). The general characteristics age, gender, height, body weight, waist and hip circumferences were collected. Diabetes mellitus , cardiovascular diseases, renal impairment, liver dysfunction, thyroid disorders history of acute myocardial infarction, stroke, and peripheral vascular disease, Gout, alcoholics, smokers, are excluded from the study. Fifty healthy sex and age matched subjects were selected as controls.

Blood pressure measurement

Blood pressure (BP) assessed by Mercury Sphygmomanometer with the patients in a sitting position, legs uncrossed. After 5 minutes of rest in the sitting position, BP was measured on both arms and the higher of the two is taken into consideration. Based on the average of two or more properly measured, seated BP readings on each of two or more office visits.

Biochemical analysis

Fasting venous blood samples were obtained from the study subjects and centrifuged at 3000 rpm for 15 min. Routine laboratory investigations were performed immediately using autoanalyser and aliquots were stored at −80 °C for further estimation of serum YKL-40, CRP levels. Glucose, serum cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, Urea, Creatinine, Uric acid levels were assessed by standardized protocols using ERBA EM-360 fully automated analyzer. Serum YKL-40 by ELISA, CRP assessed by turbilatex method.

Statistical analysis

Statistical analysis carried out with SPSS 25.0 software and values were expressed as mean ± standard deviation, p value < 0.05 was considered as statistical significant. The Pearson correlation test was used for correlation analysis.

Results

Table 1

Difference betweenAge, BMI, Waist hip ratio, systolic and diastolic blood pressure in controls, Hypertensive Patients

Parameters Controls (n=50) Prehypertension subjects (n=50) p-value
Age 38.9±5.2 39.8±5.8 0.08
Body mass index 23.7±1.9 29.5±2.95 0.01
Waist/Hip ratio 0.91±0.06 0.97±0.05 0.01
Systolic BP (mm Hg) 112.4±6.4 184.0±12.1 0.01
Diastolic (mm Hg) 74.5±3.7 109.8±7.6 b*, c* 0.01

[i] Data are expressed as mean ±SD p value <0.05 was considered statistically significant.

Table 2

Difference between fasting plasma glucose, Lipid profile, Urea, Creatinine, Uric acid,YKL-40, CRP, parameters in controls and Hypertensive subjects

Parameters Controls (n=50) Prehypertension subjects (n=50) p value
FPG(mg/dl) 84.8±10.2 93.1±14.4 0.07
Serum cholesterol (mg/dl) 187.3±8.6 230.7±18.7 0.01
Serum Triglycerides (mg/dl) 112.6±10.2 200.9±18.6 0.01
HDL cholesterol (mg/dl) 40.1±5.4 38.3±7.8 0.03
LDL cholesterol (mg/dl) 120.6±13.7 167.1±16 0.01
Serum urea(mg/dl) 24.7±5.2 25.3±7.0 0.06
Serum creatinine(mg/dl) 0.73 ±0.1 0.82±0.3 0.07
Uric acid (mg/dl) 5.5±1.6 7.8±1.2 0.02
YKL-40 (ng/ml) 19.2.0±6.9 39.7±7.1 0.01
C RP (mg/L) 1.5±0.3 8.4±1.8 0.01

Data are expressed as mean ±SD p<0.05 was considered statistically significant.

Table 3

Correlation between YKL-40 &measured parameters in Hypertensive patients

Parameters Hypertension (Correlation Coefficient-r)
CRP 0.423**
Uric acid 0.321**
Cholesterol 0.532**
TGL 0.417*
HDL -0.321*
LDL 0.532**
BMI 0.221
Waist /Hip ratio 0.254
Systolic BP 0.267
Diastolic BP 0.351*

[i] *Correlation is significant at the 0.05 level (2-tailed).

[ii] **Correlation is significant at the 0.01 level (2-tailed).

Discussion

There are continuous challenges in aspect of hypertension research. Hypertension is a major public health problem with rapid increasing prevalence of hypertension and cardiovascular morbidity and mortality in India. Hypertension is also most determinant factor for chronic kidneydisease (CKD).The Biochemical and genetic basis of gene environment interaction that may lead to elevated Blood Pressure. Hence in the present study we explored different biochemical parameters like YKL-40, CRP and uric acid levels in hypertension compared with healthy volunteers. The present study observed body mass index and (BMI) and Waist hip ratio were significantly increased in hypertensive patients compared healthy control subjects. Excess weight reflects increased body mass index, which is risk factor for hypertension, as reported earlier studies.16, 17 Visceral adiposity, releases various adipokines that are related to a decrease in the production and use of nitric oxide that in term lead to endothelial dysfunction and hypertension.18, 19

The present study observed increased total cholesterol, triglycerides, LDL cholesterol and decreased HDL cholesterol levels in hypertensive patients compared with healthy controls. Dyslipidemia affects functional, structural arterial properties and impair blood pressure regulation, which in turn promotes hypertension and atherosclerosis.20, 21 YKL-40 levels were significantly increased in hypertensive patients compared with healthy controls. YKL-40 is an inflammatory marker in acute and chronic inflammatory conditions, secreted by macrophages, neutrophils and vascular smooth muscle cells. YKL-40 could act as a chitin sensor, switching on innate defenses, helping to direct macrophages to the site of invasion and to regulate the inflammatory response as a consequence of infection.22, 23 YKL-40 levels also affect cell migration and tissue remodeling, which lead to vascular endothelial dysfunction.24

In the present study we observed CRP and uric acid levels were significantly increased in hypertensive patients compared with healthy controls. Pro-inflammatory CRP synthesized mainly by hepatocytes during inflammatory processes and serum CRP concentrations are associated with risk of atherosclerosis and cardiovascular disease.25, 26

Kang DH et al., Uric acid induces inflammatory pathways and vascular remodeling is related with expression of CRP in human vascular smooth muscle cells.27 Furthermore uric acid induce cell proliferation and oxidative stress promote endothelial dysfunction and vascular complications.28

The present study also Shows YKL-40 levels positively correlated with CRP and Uric acid levels. So, therefore, elevated levels of YKL-40 seems to be of pathological importance in the low-grade inflammation that precedes the development of vascular complications in hypertensive patients.

Conclusion

YKL-40 is considered as potential diagnostic marker for the assessment of vascular complications in hypertension. Regular monitoring might be useful for reduction of vascular complications in hypertensive patients. Further longitudinal studies are required for confirm it.

Source of Funding

None.

Conflict of Interest

None.

References

1 

S Yusuf S Hawken S Ounpuu T Dans A Avezum F Lanas INTERHEART Study Investigators . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet200436493752

2 

Paul Muntner Mark Woodward Devin M. Mann Daichi Shimbo Erin D. Michos Roger S. Blumenthal Comparison of the Framingham Heart Study Hypertension Model With Blood Pressure Alone in the Prediction of Risk of HypertensionHypertens20105561339450194-911X, 1524-4563Ovid Technologies (Wolters Kluwer Health)

3 

René R S Packard Peter Libby Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk PredictionClin Chem200854124380009-9147, 1530-8561Oxford University Press (OUP)

4 

Bernardo Rodriguez-Iturbe Hector Pons Richard J. Johnson Role of the Immune System in HypertensionPhysiol Rev20179731127640031-9333, 1522-1210American Physiological Society

5 

Alisa D. Kjaergaard Stig E. Bojesen Julia S. Johansen Børge G. Nordestgaard Elevated plasma YKL-40 levels and ischemic stroke in the general populationAnn Neurol2010685672800364-5134Wiley

6 

Camilla Noelle Rathcke Stine Brinkloev Thomsen Allan Linneberg Henrik Vestergaard Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic StrokePLoS ONE201278e434981932-6203Public Library of Science (PLoS)

7 

J. Kastrup J. S. Johansen P. Winkel J. F. Hansen P. Hildebrandt G. B. Jensen High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery diseaseEur Heart J20093091066720195-668X, 1522-9645Oxford University Press (OUP)

8 

Carole Ober Zheng Tan Ying Sun Jennifer D. Possick Lin Pan Raluca Nicolae Effect of Variation inCHI3L1on Serum YKL-40 Level, Risk of Asthma, and Lung FunctionNew Engl J Med2008358161682910028-4793, 1533-4406Massachusetts Medical Society

9 

Anders R. Nielsen Peter Plomgaard Karen S. Krabbe Julia S. Johansen Bente K. Pedersen IL-6, but not TNF-α, increases plasma YKL-40 in human subjectsCytokine201155115251043-4666Elsevier BV

10 

Geoffrey L. Chupp Chun Geun Lee Nizar Jarjour Yun Michael Shim Carole T. Holm Susan He A Chitinase-like Protein in the Lung and Circulation of Patients with Severe AsthmaNew Engl J Med2007357202016270028-4793, 1533-4406Massachusetts Medical Society

11 

Chun Geun Lee Carla A. Da Silva Charles S. Dela Cruz Farida Ahangari Bing Ma Min-Jong Kang Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and InjuryAnn Rev Physiol20117314795010066-4278, 1545-1585Annual Reviews

12 

P Libby Inflammation in atherosclerosisArterioscler Thromb Vasc Biol2012329204551

13 

Nicola R Sproston Jason J Ashworth Role of C-Reactive Protein at Sites of Inflammation and InfectionFront Immunol20189754

14 

Daniel I. Feig Duk-Hee Kang Richard J. Johnson Uric Acid and Cardiovascular RiskNew Engl J Med2008359171811210028-4793, 1533-4406Massachusetts Medical Society

15 

Richard J. Johnson Duk-Hee Kang Daniel Feig Salah Kivlighn John Kanellis Susumu Watanabe Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?Hypertens2003411183900194-911X, 1524-4563Ovid Technologies (Wolters Kluwer Health)

16 

R N Feng C Zhao C Wang Y C Niu K Li F C Guo BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adultsJ Epidemiol201222317323

17 

Y Chen X Liang S Zheng Y Wang W Lu Association of Body Fat Mass and Fat Distribution with the Incidence of Hypertension in a Population-Based Chinese Cohort: A 22-Year Follow-UpJ Am Heart Assoc201877153

18 

John N. Fain Atul K. Madan M. Lloyd Hiler Paramjeet Cheema Suleiman W. Bahouth Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese HumansEndocrinol200414552273820013-7227, 1945-7170The Endocrine Society

19 

Vasilios Kotsis Stella Stabouli Sofia Papakatsika Zoe Rizos Gianfranco Parati Mechanisms of obesity-induced hypertensionHypertension Research20103353863930916-9636, 1348-421410.1038/hr.2010.9Springer Science and Business Media LLChttps://dx.doi.org/10.1038/hr.2010.9

20 

Ian B Wilkinson Krishna Prasad Ian R Hall Anne Thomas Helen MacCallum David J Webb Increased central pulse pressure and augmentation index in subjects with hypercholesterolemiaJ Am Coll Cardiol20023961005110735-1097Elsevier BV

21 

M A Creager J P Cooke M E Mendelsohn S J Gallagher S M Coleman J Loscalzo Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.J Clin Investig1990861228340021-9738American Society for Clinical Investigation

22 

C Nojgaard N B Høst I J Christensen Serum levels of YKL-40 increases in patients with acute myocardial infarctionCoronary Artery Dis200819425763

23 

Mine Kucur Ferruh K. Isman Bilgehan Karadag Vural A. Vural Sedat Tavsanoglu Serum YKL-40 levels in patients with coronary artery diseaseCoronary Artery Disease2007183913960954-6928Ovid Technologies (Wolters Kluwer Health)10.1097/mca.0b013e328241d991https://dx.doi.org/10.1097/mca.0b013e328241d991

24 

Serap DURU Gülbahar YÜCE Hikmet FIRAT Bengül ŞİMŞEK Fatma UÇAR Sadık ARDIÇ YKL-40: Obstrüktif uyku apne sendromunda yeni bir inflamatuvar biyobelirteç olarak kullanılabilir mi?Tuberkuloz ve Toraks201563158640494-1373Bilimsel Tip Publishing House

25 

Yi Wu Lawrence A. Potempa Driss El Kebir János G. Filep C-reactive protein and inflammation: conformational changes affect functionBiol Chem2015396111181971431-6730, 1437-4315Walter de Gruyter GmbH

26 

Enrico Ammirati Francesco Moroni Giuseppe Danilo Norata Marco Magnoni Paolo G. Camici Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid AtherosclerosisMediators Inflamm201520150962-9351, 1466-186110.1155/2015/718329

27 

D H Kang S K Park I K Lee R J Johnson Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cellsJ Am Soc Nephrol20051612355362

28 

Francesca Viazzi Giovanna Leoncini Elena Ratto Roberto Pontremoli Serum Uric Acid as a Risk Factor for Cardiovascular and Renal Disease: An Old Controversy RevivedJ Clin Hypertens20068751081524-6175, 1751-7176Wiley



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

168-171


Authors Details

K Balu Mahendran, T Santhi


Article Metrics


View Article As

 


Downlaod Files